投资要点：事件：公司公布2025年三季报。公司2025年前三季度实现收入50.26亿元，同比下降0.82%；归母净利润10.20亿元，同比上升25.45%；扣非归母净利润3.26亿元，同比下降63.46%。单季度看，公司2025Q3实现收入17.75亿元，同比增长3.86%；归母净利润6.37亿元，同比增长98.73%；扣非归母净利润1.15亿元，同比下降54.25%。国内临床CRO面临价格压力，...
Source Link投资要点：事件：公司公布2025年三季报。公司2025年前三季度实现收入50.26亿元，同比下降0.82%；归母净利润10.20亿元，同比上升25.45%；扣非归母净利润3.26亿元，同比下降63.46%。单季度看，公司2025Q3实现收入17.75亿元，同比增长3.86%；归母净利润6.37亿元，同比增长98.73%；扣非归母净利润1.15亿元，同比下降54.25%。国内临床CRO面临价格压力，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.